Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies
Abroad (travel likely)Recruiting
Conditions
Mortality in Sickle Cell · Sickle Cell Cardiopulmonary Complications · Sickle Cell Organ Damage · Sickle Cell Life Expectancy and Risk Factors for Early Death · Sickle Cell Lung Disease and Sudden Death
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) · ccopr@nih.gov · 800-411-1222
Study leads
Courtney F Joseph, M.D.
Principal Investigator
National Heart, Lung, and Blood Institute (NHLBI)